Achyut Healthcare Limited

543499

INE0K1401012

Pharmaceuticals

Market Closed - Bombay S.E. Other stock markets 06:00:56 2024-07-01 am EDT			5-day change	1st Jan Change
50 ^INR	-11.82%		-11.82%	-13.79%

May. 28	Achyut Healthcare Turns to Profit in Fiscal Q4	MT
Jan. 16	Achyut Healthcare Limited announced that it has received INR 157.248 million in funding	CI

Parag Sandip Kumar Dave Resigns as Company Secretary Cum Compliance Officers of Achyut Healthcare

November 12, 2022 at 02:36 am EST

Achyut Healthcare Limited announced that Parag Sandipkumar Dave resigning from position as a Company Secretary cum Compliance Officers with effect from November 12, 2022 due to personal reason.

Latest news about Achyut Healthcare Limited

Achyut Healthcare Turns to Profit in Fiscal Q4	May. 28	MT
Achyut Healthcare Limited announced that it has received INR 157.248 million in funding	Jan. 15	CI
Achyut Healthcare Limited announced that it expects to receive INR 205.758 million in funding	Nov. 14	CI
Achyut Healthcare Limited Reports Earnings Results for the Half Year Ended September 30, 2023	Nov. 04	CI
Achyut Healthcare Limited Reports Earnings Results for the Full Year Ended March 31, 2023	23-05-27	CI
Achyut Healthcare Limited Announces Appointment of Company Secretary and Compliance Officer	23-04-14	CI
3,592,800 Equity Shares of Achyut Healthcare Limited are subject to a Lock-Up Agreement Ending on 25-MAR-2023.	23-03-24	CI
Achyut Healthcare Board to Consider Issuance of Bonus Shares	23-03-14	MT
Achyut Healthcare to Allot Nearly 3 Million Shares to Promoters, Non-Promoters	23-01-05	MT
Achyut Healthcare Limited announced that it has received INR 52.08 million in funding from Ray Remedies Private Limited, Sera Investments & Finance India Limited, Everon Advisors Private Limited	23-01-04	CI
Achyut Healthcare Limited announced that it expects to receive funding	22-11-16	CI
Parag Sandip Kumar Dave Resigns as Company Secretary Cum Compliance Officers of Achyut Healthcare	22-11-12	CI
Achyut Healthcare Limited Reports Earnings Results for the Half Year Ended September 30, 2022	22-11-12	CI
Achyut Healthcare Limited has completed an IPO in the amount of INR 36 million.	22-03-25	CI
Achyut Healthcare Limited has filed an IPO.	21-12-22	CI

Chart Achyut Healthcare Limited

Duration

Period

More charts

Achyut Healthcare Limited is an India-based pharmaceutical trading company. The Company is focused on dealing in active pharmaceutical ingredients (API), pharmaceutical products, and medical devices. The Company is engaged in the business of pharmaceutical formulations in the forms of tablets, capsules, oral liquid and injectable. The Company is engaged in trading of Cenzure, Arpimune, Azathioprine IP, Everomimus, Mycophenolate Mofetil USP, Mycophenolate Sodium USP, Sirolimus, Tacrolimus USP, Infrared thermometer, Ascorbic Acid Coated Vitamin C, Calcium carbonate oyster, Cellulose acetate Phthalate, Chlorthalidone IP, Cross Carmalose Sod IP/USP, DI Basic Calcium Phosphate IP, DI Ethyl Phthlate, Diltiazem Hydrochloride IP, Easy Coat Fc Titanium Dioxide, Escitalopram IP, Escitalopram Oxalate, Favipiravir among many other products.

Sector

Pharmaceuticals

Calendar

2024-11-10 - Q2 2025 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
ACHYUT HEALTHCARE LIMITED	-13.79%	10.08M
ELI LILLY AND COMPANY	+56.89%	823B
NOVO NORDISK A/S	+39.52%	627B
JOHNSON & JOHNSON	-6.55%	353B
ABBVIE INC.	+7.92%	295B
ASTRAZENECA PLC	+13.74%	239B
NOVARTIS AG	+13.83%	220B
ROCHE HOLDING AG	-0.49%	219B
AMGEN INC.	+7.94%	167B
PFIZER, INC.	-2.57%	159B